<DOC>
	<DOCNO>NCT02632279</DOCNO>
	<brief_summary>The purpose study assess effect tryptophan depletion mood behavior Parkinson 's disease ( PD ) patient treat deep brain stimulation ( DBS ) subthalamic nucleus ( STN ) . By , investigator hope able identify risk factor mechanisms underlie psychiatric side effect STN DBS . The study intervention study placebo control , randomize cross-over design .</brief_summary>
	<brief_title>Tryptophan Depletion PD Patients Treated With STN DBS</brief_title>
	<detailed_description>Parkinson 's disease ( PD ) neurodegenerative disorder characterize motor symptom tremor , rigidity slowness movement . In late stage disease , pharmacological treatment become less efficient , deep brain stimulation ( DBS ) subthalamic nucleus ( STN ) become treatment option . Although motor symptom improve significantly DBS , number operate patient experience severe side effect , mostly related mood , cognition behavior . These adverse effect likely mediate serotonin ( 5-HT ) system . Additionally , dysfunction 5-HT system implied pathophysiology PD . PD patient therefore regard 'vulnerable ' experience mood , cognitive emotional problem due change 5-HT activity . To elucidate whether STN DBS indeed trigger psychiatric cognitive problem arise PD patient , 5-HT level PD patient implant STN DBS manipulate . In order , investigator make use tryptophan ( TRP ) depletion method , establish research paradigm . In TRP depletion , brain deplete TRP , precursor 5-HT , consequently lead lower 5-HT level . In normal 5-HT deplete condition , mood- cognitive parameter PD patient STN stimulation ( ON ) ( OFF ) assess . The goal get insight effect STN DBS PD patient 5-HT vulnerabililty effect 5-HT related mood cognitive behaviour . This way , possible risk factor mechanisms underlie psychiatric side effect STN DBS identify . The study intervention study placebo control , randomize cross-over design .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Tryptophan</mesh_term>
	<criteria>subject must mentally competent subject must undergo STN DBS surgery PD symptomatology head injury stroke currentl malignancy infection neurological disorder PD psychoactive medication : specifically antidepressant antipsychotic ( stable dose benzodiazepine allow ) clinically relevant cognitive decline , operationalized MMSE score &lt; 24 current psychiatric syptomatology , operationalized Hamilton Depression scale score &gt; 16 score &gt; 2 one MDSUPDRS section I , item 16</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>Subthalamic nucleus</keyword>
	<keyword>Tryptophan depletion</keyword>
	<keyword>Serotonin</keyword>
</DOC>